Evotec and Pierre Fabre sign five-year compound management agreement

Evotec will handle Pierre Fabre's collection out of its compound management facility in Toulouse

German research services firm Evotec has signed a multi-year compound management agreement with Pierre Fabre Laboratories of France.

Under the terms of the agreement, Evotec will handle Pierre Fabre’s compound collection (individual compounds and collection plates) out of its compound management facility in Toulouse, France. The agreement covers an initial period of five years.

No financial details were disclosed.

Laurent Audoly, Pierre Fabre Pharmaceuticals R&D Director, said: 'Evotec will undoubtedly be an important partner for Pierre Fabre to accelerate its discovery and development pace in the fields of oncology, dermatology and CNS.'

Dr Mario Polywka, Chief Operating Officer of Evotec, added: 'This collaboration further validates our strategy to establish a state-of-the-art compound management operation out of Toulouse for the European market and cements our position as the world leader in outsourced compound management. We look forward to a long and successful partnership with Pierre Fabre.'

Companies